IngentaConnect Search Results

Clinical application of extended-release hydromorphone for pain management

Author: Grider, Jay S

Source: Therapy, Volume 6, Number 5, September 2009 , pp. 653-656(4)

Alleged Medical Abandonment in Chronic Opioid Analgesic Therapy: Case Report

Authors: Fishbain, David A.; Lewis, John E.; Gao, Jinrun; Cole, Brandly; Rosomoff, Rennee Steele

Source: Pain Medicine, Volume 10, Number 4, May/June 2009 , pp. 722-729(8)

Development of a Budget-Impact Model to Quantify Potential Cost Savings from Prescription Opioids Designed to Deter Abuse or Ease of Extraction

Authors: White, Alan G.; Birnbaum, Howard G.; Rothman, Dov B.; Katz, Nathaniel

Source: Applied Health Economics and Health Policy, Volume 7, Number 1, 1 March 2009 , pp. 61-70(10)

Publisher: Adis International

Pain Treatment with Opioids: Achieving the Minimal Effective and the Minimal Interacting Dose

Authors: Geppetti, Pierangelo; Benemei, Silvia

Source: Clinical Drug Investigation, Volume 29, Supplement 1, 2009 , pp. 3-16(14)

Publisher: Adis International

Enteral Controlled-Release Opioid Delivery Systems

Author: Smith, Howard S.

Source: Pain Medicine, Volume 10, Supplement 1, April 2009 , pp. S30-S38(1)

Publisher: Blackwell Publishing

Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone

Authors: Ward, Alexandra; Bozkaya, Duygu; Fleischmann, Jochen; Dubois, Dominique; Sabatowski, Rainer; Caro, J. Jaime

Source: Current Medical Research and Opinion, Volume 23, Number 10, October 2007 , pp. 2333-2345(13)

Publisher: Informa Healthcare

Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO-127)

Authors: Wallace, Mark; Skowronski, Roman; Khanna, Sarita; Tudor, Iulia Cristina; Thipphawong, John

Source: Current Medical Research and Opinion, Volume 23, Number 5, May 2007 , pp. 981-989(9)

Publisher: Informa Healthcare

PTI-821: sustained-release oxycodone using gel-cap technology

Author: Webster, Lynn R

Source: Expert Opinion on Investigational Drugs, Volume 16, Number 3, March 2007 , pp. 359-366(8)

Publisher: Informa Healthcare

Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany

Authors: Greiner, W.; Lehmann, K.; Earnshaw, S.; Bug, C.; Sabatowski, R.

Source: The European Journal of Health Economics, Volume 7, Number 4, December 2006 , pp. 290-296(7)

Publisher: Springer

Hydromorphone in elderly patients with polypathia and with severe pain

Authors: Nadstawek, J.; Wartenberg, H.C.; Schenk, M.; Wirz, S.

Source: The Pain Clinic, Volume 18, Numbers 5-6, 2006 , pp. 403-413(11)

Publisher: Maney Publishing

A Study of AVINZA^® (Morphine Sulfate Extended-Release Capsules) for Chronic Moderate-to-Severe Noncancer Pain Conducted Under Real-World Treatment Conditions—The ACCPT Study

Authors: Adams, Edgar H.; Chwiecko, Paul; Ace-Wagoner, Yvonne; Mangefrida, Bethany; Duerden, Mark E.; Perdikis, George C.; Kunkel, Frank A.; Ghalie, Richard

Source: Pain Practice, Volume 6, Number 4, December 2006 , pp. 254-264(11)

Publisher: Blackwell Publishing

Chronic pain service: A retrospective descriptive analysis of in-hospital pain consultations

Authors: Pöyhiä, R.; Heiskanen, T.; Kalso, E.; Hamunen, K.

Source: The Pain Clinic, Volume 18, Number 2, 2006 , pp. 109-117(9)

Publisher: Maney Publishing

Co-ingestion of controlled-release opioids + alcohol may harm

Source: Reactions, Volume 1, Number 1064, 2005-08-13 , pp. 3-3(1)

Publisher: Adis International

Co-ingestion of controlled-release opioids + alcohol may harm

Source: Inpharma, Volume 1, Number 1500, 2005-08-13 , pp. 17-17(1)

Publisher: Adis International

A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study to Assess the Effects of Long-Term Opioid Drug Consumption and Subsequent Abstinence in Chronic Noncancer Pain Patients Receiving Controlled-Release Morphine

Authors: Cowan David T.; Wilson-Barnett Dame Jenifer; Griffiths Peter; Vaughan David J. A.; Gondhia Anjalee; Allan Laurie G.

Source: Pain Medicine, Volume 6, Number 2, March 2005 , pp. 113-121(9)

Publisher: Blackwell Publishing

Oxycodone Involvement in Drug Abuse Deaths. II. Evidence for Toxic Multiple Drug-Drug Interactions

Authors: Edward J. Cone; Reginald V. Fant; Jeffrey M. Rohay; Yale H. Caplan; Mayra Ballina; Robert F. Reder; J. David Haddox

Source: Journal of Analytical Toxicology, Volume 28, Number 7, October 2004 , pp. 616-624(9)

Publisher: Preston Publications

Efficacy and Safety Assessment of a Novel Once-Daily Tablet Formulation of Tramadol: A Randomised, Controlled Study versus Twice-Daily Tramadol in Patients with Osteoarthritis of the Knee

Authors: Gérald Mongin; Vladimir Yakusevich; Adorjan Köpe; Nadezhda Shostak; Eduard Pikhlak; Laszlo Popdán; Judit Simon; Catherine Navarro; Louise Fortier; Sybil Robertson; Sylvie Bouchard

Source: Clinical Drug Investigation, Volume 24, Number 9, 2004 , pp. 545-558(14)

Publisher: Adis International

Oxycodone Involvement in Drug Abuse Deaths. II. Evidence for Toxic Multiple Drug-Drug Interactions

Authors: Edward J. Cone; Reginald V. Fant; Jeffrey M. Rohay; Yale H. Caplan; Mayra Ballina; Robert F. Reder; J. D. Haddox

Source: Journal of Analytical Toxicology, Volume 28, Number 4, May/June 2004 , pp. 217-225(9)

Publisher: Preston Publications

Avinza® – 24-h sustained-release oral morphine therapy

Author: Caldwell J.R.

Source: Expert Opinion on Pharmacotherapy, Volume 5, Number 2, 1 February 2004 , pp. 469-472(4)

Publisher: Informa Healthcare

Conversion to Oral Controlled-Release Oxycodone From Intravenous Opioid Analgesic in the Postoperative Setting

Authors: Ginsberg B.; Sinatra R.S.; Adler L.J.; Crews J.C.; Hord A.H.; Laurito C.E.; Ashburn M.A.

Source: Pain Medicine, Volume 4, Number 1, March 2003 , pp. 31-38(8)

Publisher: Blackwell Publishing